Sandostatin LAR depot 10 MG KTS
Ended Awarded Last action
- Contract number
- SPE2DR26F9U29
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,014
Award facts
- Contract value 100% obligated
- $17,014.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,014.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Sandostatin LAR Depot 10 mg kits, with a completion date of January 5, 2026. The award was executed without a set-aside designation through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. This delivery order represents a child contract under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026.
Sandostatin LAR Depot is a specialty pharmaceutical product used in endocrinology and oncology applications. The delivery order falls within AmerisourceBergen Drug Corp's comprehensive pharmaceutical supply portfolio, which includes brand-name and generic medications, specialty drugs, and medical supplies across multiple therapeutic domains supporting Defense Health Agency operations and other federal healthcare systems. The firm fixed-price structure and rapid completion timeline reflect the operational nature of pharmaceutical delivery orders under the broader DLA Troop Support Medical contract vehicle, which provides global pharmaceutical support capabilities to military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26F9U29?
SPE2DR26F9U29 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 2, 2026.
How much is contract SPE2DR26F9U29 worth?
The government has obligated $17,014 on SPE2DR26F9U29.
Is contract SPE2DR26F9U29 an order under another contract?
Yes. SPE2DR26F9U29 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9U29 competed?
The extent of competition for SPE2DR26F9U29 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award